Details for New Drug Application (NDA): 203978
✉ Email this page to a colleague
The generic ingredient in NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
Summary for 203978
Tradename: | NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE |
Applicant: | Inforlife |
Ingredient: | nicardipine hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 203978
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 20MG/200ML (0.1MG/ML) | ||||
Approval Date: | Apr 17, 2024 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 40MG/200ML (0.2MG/ML) | ||||
Approval Date: | Apr 17, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription